Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1352-1360

  Tsuji, Takanori ^a   Sun, Yeqing ^a,b   Kishimoto, Koji ^a,c   Olson, Karen A ^a,d   Liu, Shumei ^a   Hirukawa, Saori ^a   Hu, Guo Fu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DALIAN MARITIME UNIVERSITY   (China)

^c OKAYAMA UNIVERSITY   (Japan)

^d Archemix Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; COMPLEMENTARY RNA; RIBOSOME RNA;

ARTICLE; BIOGENESIS; CARCINOGENESIS; CELL DENSITY; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE TRANSLOCATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL GROWTH PROCESSES; CELL NUCLEUS; CELLS, CULTURED; DNA, ANTISENSE; ENDOTHELIUM, VASCULAR; HELA CELLS; HUMANS; MICE; MICE, NUDE; RIBONUCLEASE, PANCREATIC; RIBOSOMES; RNA INTERFERENCE; RNA, RIBOSOMAL; TRANSFECTION; TUMOR STEM CELLS; UP-REGULATION;

EID: 13944277097     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2058     Document Type: Article

References (45)

1. Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480-6.
2. Olson KA, Fett JW, French TC, Key ME, Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci U S A 1995;92:442-6.
3. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001;7:3598-605.
4. Montero S, Guzman C, Cortes-Funes H, Colomer R. Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res 1998;4:2161-8.
5. Chopra V, Dinh TV, Hannigan EV. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-9.
6. Li D, Bell J, Brown A, Berry CL. The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 1994;172:171-5.
7. Shimoyama S, Shimizu N, Tsuji E, et al. Distribution of angiogenin and its gene message in colorectal cancer patients and their clinical relevance. Anticancer Res 2002;22:1045-52.
8. Chopra V, Dinh TV, Hannigan EV. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol 1997;123:167-72.
9. Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 2000;126:468-74.
10. Wechsel HW, Bichler KH, Feil G, et al. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 1999;19:1537-40.
11. Barton DP, Cai A, Wendt K, et al. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 1997;3:1579-86.
12. Shimoyama S, Gansauge F, Gansauge S, et al. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 1996;56:2703-6.
13. Majumder PK, Yeh JJ, George DJ, et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci U S A 2003;100:7841-6.
14. Miyake H, Hara I, Yamanaka K, et al. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer 1999;86:316-24.
15. Eberle K, Oberpichler A, Trantakis C, et al. The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res 2000;20:1679-84.
16. Verstovsek S, Kantarjian H, Aguayo A, et al. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome. Br J Haematol 2001;114:290-5.
17. Park YW, Kim SM, Min BG, Park IW, Lee SK. Lymphangioma involving the mandible: immunohistochemical expressions for the lymphatic proliferation. J Oral Pathol Med 2002;31:280-3.
18. Hartmann A, Kunz M, Kostlin S, et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999;59:1578-83.
19. Skoldenberg EG, Christiansson J, Sandstedt B, et al. Angiogenesis and angiogenic growth factors in Wilms tumor. J Urol 2001;165:2274-9.
20. Hu GF. Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci U S A 1998;95:9791-5.
21. Moroianu J, Riordan JF. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A 1994;91:1677-81.
22. Hu G, Xu C, Riordan JF. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J Cell Biochem 2000;76:452-62.
23. Li R, Riordan JF, Hu G. Nuclear translocation of human angiogenin in cultured human umbilical artery endothelial cells is microtubule and lysosome independent. Biochem Biophys Res Commun 1997;238:305-12.
24. Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A 1994;91:12096-100.
25. Hu GF, Riordan JF, Vallee BL. A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc Natl Acad Sci U S A 1997;94:2204-9.
26. Jimi S, Ito K, Kohno K, et al. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem Biophys Res Commun 1995;211:476-83.
27. Fu X, Roberts WG, Nobile V, Shapiro R, Kamps MP. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors 1999;17:125-37.
28. Xu ZP, Tsuji T, Riordan JF, Hu GF. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun 2002;294:287-92.
29. Xu ZP, Tsuji T, Riordan JF, Hu GF. Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 2003;42:121-8.
30. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
31. Kuo BA, Gonzalez IL, Gillespie DA, Sylvester JE. Human ribosomal RNA variants from a single individual and their expression in different tissues. Nucleic Acids Res 1996;24:4817-24.
32. Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 2002;99:5515-20.
33. Fett JW, Olson KA, Rybak SM. A monoclonal antibody to human angiogenin. Inhibition of ribonucleolytic and angiogenic activities and localization of the antigenic epitope. Biochemistry 1994;33:5421-7.
34. Chavali GB, Papageorgiou AC, Olson KA, et al. The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody. Structure 2003;11:875-85.
35. Ruschoff J, Plate K, Bittinger A, Thomas C. Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology. Pathol Res Pract 1989;185:878-85.
36. Trere D, Pession A, Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 1989;184:131-7.
37. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3.
38. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003;11:415-24.
39. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002;98:923-9.
40. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003;3:179-92.
41. Phelps C, Hymer WC. Characterization of estrogen-induced adenohypophyseal tumors in the Fischer 344 rat. Neuroendocrinology 1983;37:23-31.
42. Ying C, Gregg DW, Gorski J. Estrogen-induced changes in rRNA accumulation and RNA polymerase I activity in the rat pituitary: correlation with pituitary tumor susceptibility. Mol Cell Endocrinol 1996;118:207-13.
43. Montie JE, Pienta KJ. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 1994;43:892-9.
44. Mainwaring WI, Derry NS. Enhanced transcription of rRNA genes by purified androgen receptor complexes in vitro. J Steroid Biochem Mol Biol 1983;19:101-8.
45. Kabler RL, Srinivasan A, Taylor LJ, et al. Androgen regulation of ribosomal RNA synthesis in LNCaP cells and rat prostate. J Steroid Biochem Mol Biol 1996;59:431-9.